| Market Cap | ₹29,575Cr |
| ROE | 8.27% |
| P/E Ratio(TTM) | 34.91 |
| EPS(TTM) | 51.42 |
| P/B Ratio | 3.09 |
| Dividend Yield | 1.00% |
| Industry P/E | 32.50 |
| Book Value | 580.41 |
| Debt to Equity | 0.03 |
| Face Value | 1 |
| Managing Director | Srinivas Sadu |
| Founded | 1978 |
| NSE Symbol | GLAND |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 65.11 | ||
| Ajanta Pharma | NA (0.00%) | 36.51 | ||
| Sai Life Sciences | NA (0.00%) | 63.35 | ||
| Eris Lifesciences | NA (0.00%) | 40.12 |